Back

Effectiveness and safety of edge-to-edge MItral vaLve repair in patients with significant mitraL rEgurgitatioN aNd cardIac ATTR amyloidosis: design and rationale of the MILLENNIAL trial

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac amyloidosis (2) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Laurenz Hauptmann

Medical University of Vienna, Vienna (Austria)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Doctor N. Mora Ayestaran (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
Professor J. Smith (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Doctor A. Roldan Guerra (Cordoba, ES)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac amyloidosis (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Session
HOT LINE 3
thumbnail
Congress Presentation
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
thumbnail
Congress Presentation
Tri. fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources